Yes... there have been studies of multiple drugs to treat COVID-19 in the recent couple months. some of the results look positive but a lot of the information is still speculative. Some of the drugs are existing and others are brand new. Naturally news about drugs have taken a backseat to news/studies about vaccines. A couple of recent examples of drug treatment results in the news include: Common asthma drug cuts COVID-19 hospitalization risk, recovery time - Oxford study https://www.reuters.com/article/health-coronavirus-asthma-treatment-int-idUSKBN2A92M7 A commonly used asthma treatment appears to reduce the need for hospitalizations as well as recovery time for COVID-19 patients if given within seven days of symptoms appearing, researchers at the University of Oxford said on Tuesday. The findings were made following a mid-stage study of the steroid budesonide, sold as Pulmicort by AstraZeneca Plc and also used for treating smoker’s lung. The 28-day study of 146 patients suggested that inhaled budesonide reduced the risk of urgent care or hospitalization by 90% when compared with usual care, Oxford University said. (More at above url) Feeling better ‘after 2 hours’: Israeli COVID drug for critically ill enters Phase 3 trials https://www.timesofisrael.com/liveb...rug-for-critically-ill-enters-phase-3-trials/ Channel 13 reports on experimental Israeli-made drug Allocetra, used to treat serious and critical COVID-19 cases, which has completed Phase 2 trials successfully. Of 20 seriously ill patients treated with the drug so far, 90% recovered, the report says. Allocetra treats the over-response of the immune system and inflammatory response that is sometimes seen in COVID-19 patients, called a cytokine storm. The phenomenon can cause severe immune system attacks on the body’s own organs, leading to organ failure and sometimes death. (More at above url)
Trump Was Sicker Than Acknowledged With Covid-19 When hospitalized with the coronavirus in October, his blood oxygen levels had plunged and officials feared he was on the verge of being placed on a ventilator. https://www.nytimes.com/2021/02/11/...ews&ref=cta®i_id=54641335&segment_id=51478 President Donald J. Trump was sicker with Covid-19 in October than publicly acknowledged at the time, with extremely depressed blood oxygen levels at one point and a lung problem associated with pneumonia caused by the coronavirus, according to four people familiar with his condition. His prognosis became so worrisome before he was taken to Walter Reed National Military Medical Center that officials believed he would need to be put on a ventilator, two of the people familiar with his condition said. The people familiar with Mr. Trump’s health said he was found to have lung infiltrates, which occur when the lungs are inflamed and contain substances such as fluid or bacteria. Their presence, especially when a patient is exhibiting other symptoms, can be a sign of an acute case of the disease. They can be easily spotted on an X-ray or scan, when parts of the lungs appear opaque, or white. Mr. Trump’s blood oxygen level alone was cause for extreme concern, dipping into the 80s, according to the people familiar with his evaluation. The disease is considered severe when the blood oxygen level falls to the low 90s. It has been previously reported that Mr. Trump had trouble breathing and a fever on Oct. 2, the day he was taken to the hospital, and the types of treatment he received indicated that his condition was serious. But the new details about his condition and about the effort inside the White House to get him special access to an unapproved drug to fight the virus help to flesh out one of the most dire episodes of Mr. Trump’s presidency. The new revelations about Mr. Trump’s struggle with the virus also underscore the limited and sometimes misleading nature of the information disclosed at the time about his condition. The former president resisted being taken from the White House to Walter Reed, relenting when aides told him that he could walk out on his own, or risk waiting until the U.S. Secret Service was forced to carry him out if he got sicker, two people familiar with the events said. While Mr. Trump was hospitalized at Walter Reed, his medical team sought to downplay the severity of the situation, saying that he was on an upswing. At 74 and overweight, he was at risk for severe disease, and was prescribed an aggressive course of treatments. He left the hospital after three days in which he at one point staged a brief ride in his armored sport-utility vehicle to wave at the crowd of supporters outside the building. A person close to the former president denied that he had been seriously ill, echoing comments Mr. Trump himself made after he was sick. There are still unanswered questions about whether Mr. Trump was already sick with Covid-19 when he participated in a presidential debate on Sept. 29, just two days before the public announcement that he had been diagnosed with the disease and three days before his deteriorating condition forced him to go to Walter Reed. Mr. Trump’s physician, Dr. Sean P. Conley, repeatedly downplayed concerns about Mr. Trump’s condition during his illness. At one briefing, Dr. Conley said Mr. Trump was receiving X-ray and CT scans. But when asked about whether there was evidence of pneumonia or damage to the tissue, he would only say there were “expected findings, but nothing of any major clinical concern.” Dr. Conley also told reporters that while Mr. Trump’s oxygen level had dropped to 93 percent, it had never dropped to the “low 80s.” Mr. Trump had trouble breathing at the White House. He was twice given oxygen before being taken to Walter Reed, as Dr. Conley acknowledged after it was reported by The New York Times. While still at the White House, Mr. Trump received a drug developed by the biotechnology firm Regeneron Pharmaceuticals. The antibody cocktail — not widely available at the time — helps people infected with the virus fight it off. After Mr. Trump was hospitalized, he began a regimen for a steroid, dexamethasone, which is usually recommended only for Covid-19 patients who have severe or critical forms of the disease, often those who need mechanical ventilation or supplemental oxygen.
Did the hypocrite not get cured with meds using embryonic stem cells? Hypocrite cons gonna hypocrit https://abcnews.go.com/Politics/tru...oped-cells-originally-drawn/story?id=73508455
old baby: What's True The manufacturer of REGN-COV2 has stated that it employs stem cells in its research, most commonly mouse embryonic stem cells and human blood stem cells. The "antibody cocktail" given to Trump is a combination of two human-made proteins and was developed using a decades-old cell line derived from embryonic kidney tissues obtained from an aborted human fetus in 1973. What's False However, no human embryonic stem cells or recently harvested fetal tissues were used in the development of REGN-COV2, according to the manufacturer. In the research and development of pharmaceutical therapeutics, many companies turn to what is known as a cell line. These are cultures of human or animal cells that are derived from a living organism and cultured and propagated repeatedly, and, in some cases, used indefinitely. The development of REGN-COV2 utilized HEK293T — a cell line that is derived from human fetal embryonic kidney tissues — to create a “pseudovirus” that mimics a spike Protein found in SARS-CoV-2 in order to test the drug’s ability to neutralize — and ultimately treat — the novel coronavirus. “HEK293s are considered ‘immortalized’ cells (not stem cells) and are a common and widespread tool in research labs. This cell line was originally derived by adenovirus transformation of human embryonic kidney cells in 1977,” explained Bowie, adding that HEK293 were further transformed at Stanford in the 1980s with SV40 large T antigen, a solution that is used by researchers to initiate and maintain DNA replication necessary for creating cell lines. Fetal tissues were not directly used n the development of REGN-COV2, but cell lines from decades-old embryonic kidney tissues were. Fetal tissues are used to develop cell lines. Embryonic stem cells, on the other hand, are different than adult stem cells in that they are undifferentiated and regenerative cells, which means that they have not been assigned a key task in the human body. As such, researchers have uncovered ways to direct their use in creating human tissues that allow for a variety of uses, including testing new pharmaceuticals.